Biolife Solutions (BLFS) Long-Term Deferred Tax (2010 - 2018)

Biolife Solutions' (BLFS) quarterly Long-Term Deferred Tax came in at $7.4 million in Q4 2018, down 9.57% year-on-year from $8.2 million in Q4 2017, and down 9.57% on a QoQ basis from $8.2 million in Q4 2017.

Biolife Solutions (BLFS) Long-Term Deferred Tax (2010 - 2018) Analysis & Trends

Biolife Solutions (BLFS) has 6 years of Long-Term Deferred Tax data on file, last reported at $7.4 million in Q4 2018.

  • On a quarterly basis, Long-Term Deferred Tax fell 9.57% year-over-year to $7.4 million in Q4 2018; TTM through Dec 2018 was $7.4 million, a 9.57% decrease from a year earlier, with the FY2018 full-year figure at $7.4 million, down 9.57% from the prior year.
  • Long-Term Deferred Tax for Q4 2018 stood at $7.4 million, down from $8.2 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for BLFS reached as high as $8.2 million in Q4 2017 and fell as low as $7.4 million in Q4 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn
10 Biolife Solutions 1.44 Bn 1.36 Bn 17.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2018 7.38 Mn
Dec 31, 2017 8.16 Mn
Dec 31, 2013 114,874.00
Jun 30, 2013 143,399.00
Mar 31, 2013 157,506.00
Dec 31, 2012 171,458.00
Sep 30, 2012 189,855.00
Jun 30, 2012 208,251.00
Mar 31, 2012 84,997.00
Dec 31, 2011 112,042.00
Sep 30, 2011 139,384.00
Jun 30, 2011 70,466.00
Dec 31, 2010 97,220.00